Aeron C. Hurt, Ph.D.

Clinical Development, Shionogi & Co., Ltd., London, England, UK, United Kingdom

Disclosure(s): Shionogi, Inc.: Employee

Poster(s):

• (P-1606) Clearance of Infectious Virus in COVID-19 Patients Treated with Ensitrelvir Across Vaccination Status, Age, and Risk Subgroups: Exploratory Analyses from the SCORPIO-HR Study
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET